Alliance Growers Corp. (CSE:ACG; FWB:1LA) has provided updates on equity facility negotiations and the company’s projects that will ultimately make Alliance a successful global cannabis company. Alliance continues to deliver on its strategy to build a global cannabis company that is positioned for where the cannabis market will be, not only where it is now.
$5 Million to $10 Million Equity Facility with Private Equity Firm
In addition to the current private placement, Alliance is currently negotiating terms on an equity facility to meet our capital requirements for the following projects.
Property Identified for Cannabis Botany Centre
BRIM and Alliance have identified a property for the 40,000 square foot Cannabis Botany Centre. It consists of 40 acres of land in Miracle Valley, east of Mission, with the potential to develop up to 1 million square feet of facility space. This property has zoning that is approved for Health Canada Licensed Producer facilities. Thanks to the tremendous potential in the Cannabis space, we now have multiple options to finance the purchase of the land and the construction of the facility.
Strategic Alliances and Investments in Licensed Producer Applicants
Through a serious of strategic alliances and investments in Licensed Producers at various stages in the license process, Alliance is focused on securing long term plantlet supply contracts for the Cannabis Botany Centre and off-take agreements at wholesale cost for flower to be used for cannabidiol (CBD) oil extraction. Alliance will announce later this week, the final terms on a 5% non-dilutive interest in a private company in Ontario that has assembled a top tier growing team with management that has the expertise to expedite the license producer application process.
Additional Licensed Producer Applicants have approached Alliance looking to partner with a public company and negotiations are ongoing.
Read the full company profile.
Permits Secured by Israeli Medical Cannabis Company
Further to the company’s commitment to become a leading supplier of pharmaceutical grade CBD oil on a global basis, Alliance continues discussions setting out terms for an equity investment and/or joint venture with an Israeli medical cannabis company.
Last week the Company was informed that all permits were in place on 45-50 hectares of land for the growth of high quality cannabis plants in an offshore, low operating cost jurisdiction. The Israeli medical cannabis company brings first-class technology for production and processing based on Israeli technology in addition to specific strains and processing knowhow. This would facilitate the importation of the CBD Oil into various states in the USA, into Canada when legalized, and into countries like Germany now that the laws have changed. We expect many more European countries to follow suit in the months to come.
The Hemp Business Journal reports that the CBD market is growing at a rate of 30% per annum, and forecasts that sales of CBD Oils from marijuana-based sources are expected to reach $1,650,000,000, or 79% of the total CBD Market of $2,100,000,000 by 2020. And this is in the USA only. Dennis Petke, President and CEO stated “We are very excited to for the opportunity to take advantage of the equity facility to execute on our business plan. The equity firm we are negotiating with has financed other well-known Canadian Cannabis companies in the past 2 years. Over time we expect new investors and our shareholders to begin to see that we are building a global cannabis company that stands out from other Canadian cannabis companies whose entire business is directly affected by Health Canada rules and regulations.”
Connect with Alliance Growers Corp. (CSE:ACG; FWB:1LA) to receive an Investor Presentation.

  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less